Integrated Animal Health (IAH) is a new breed of animal health company. IAH is an innovation engine, with one of the deepest pipelines in the industry today. Originally founded in Australia, they moved their global operations to Lawrence, Kansas, in the Animal Health Corridor in 2015.

As the animal pharmaceutical and pet food industries have grown and merged, innovation has slowed. Of the relatively few drugs approved by FDA last year, nearly half were antibiotics. IAH innovates faster and less expensively. They launched five new products in the past 12 months, all non-antibiotic, non-pesticide solutions, and each, truly, a transformative innovation.

IAH creates value by early identification of novel technologies. They then de-risk these innovations through testing, regulatory approval and commercialization, launching these products in big markets with unmet needs through licensing or global distribution. The product technologies are for production animals as well as pets and run the gamut from nutraceuticals to pharmaceuticals, novel pet foods and animal feeds to biologics.

Integrated Animal Health has commercially tested and available products already going into global distribution with 10 international territories signed in less than 12 months. Their small team has many decades of experience working across two dozen countries and five continents.

IAH products address significant and costly issues like an all-natural non-pesticide tick and fly control for feedlot cattle, deer, horses, dogs and cats (which has no equivalent market competitor); non-antibiotic, certified organic, all-natural solutions for dairy mastitis and calf scours (diarrhea); biotoxin control; cancer therapies; a nutraceutical treat line and much more. IAH currently has five trials ongoing with large, multinational corporations in dairy, swine and companion pets in either proof of concept or field studies.

IAH delivers innovation that matters.